Vor Biopharma/$VOR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Vor Biopharma
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Ticker
$VOR
Sector
Primary listing
Employees
76
Headquarters
Website
Vor Biopharma Metrics
BasicAdvanced
$892m
-
-$70.50
1.92
-
Price and volume
Market cap
$892m
Beta
1.92
52-week high
$49.95
52-week low
$6.50
Average daily volume
1.1m
Financial strength
Current ratio
18.2
Quick ratio
18.085
Long term debt to equity
-1.655
Total debt to equity
-1.826
Profitability
EBITDA (TTM)
-339.049
Management effectiveness
Return on assets (TTM)
-70.41%
Return on equity (TTM)
2,057.65%
Valuation
Price to book
-3.88
Price to tangible book (TTM)
-3.88
Price to free cash flow (TTM)
-1.132
Free cash flow yield (TTM)
-88.35%
Free cash flow per share (TTM)
-14.552
Growth
Earnings per share change (TTM)
107.17%
3-year earnings per share growth (CAGR)
14.82%
Vor Biopharma News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Vor Biopharma stock?
Vor Biopharma (VOR) has a market cap of $892M as of May 13, 2026.
What is the P/E ratio for Vor Biopharma stock?
The price to earnings (P/E) ratio for Vor Biopharma (VOR) stock is 0 as of May 13, 2026.
Does Vor Biopharma stock pay dividends?
No, Vor Biopharma (VOR) stock does not pay dividends to its shareholders as of May 13, 2026.
When is the next Vor Biopharma dividend payment date?
Vor Biopharma (VOR) stock does not pay dividends to its shareholders.
What is the beta indicator for Vor Biopharma?
Vor Biopharma (VOR) has a beta rating of 1.92. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.